Impact of short-term treatment with telmisartan on cerebral arterial remodeling in SHR. En savoir plus sur Impact of short-term treatment with telmisartan on cerebral arterial remodeling in SHR.
Human monocyte response to S-nitrosoglutathione-loaded nanoparticles: uptake, viability, and transcriptome. En savoir plus sur Human monocyte response to S-nitrosoglutathione-loaded nanoparticles: uptake, viability, and transcriptome.
Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation. En savoir plus sur Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
Interaction of recombinant octameric hemoglobin with endothelial cells. En savoir plus sur Interaction of recombinant octameric hemoglobin with endothelial cells.
Nitric oxide-eluting scaffolds and their interaction with smooth muscle cells in vitro. En savoir plus sur Nitric oxide-eluting scaffolds and their interaction with smooth muscle cells in vitro.
Comment on "Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles". En savoir plus sur Comment on "Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles".
Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity. En savoir plus sur Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity.
Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery. En savoir plus sur Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery.
[Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?]. En savoir plus sur [Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?].
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells. En savoir plus sur Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.
